QUINOLINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS

The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin-3 (NK-3) receptors, such as schizophrenia. La présente invention concerne d...

Full description

Saved in:
Bibliographic Details
Main Author CARLING, WILLIAM ROBERT
Format Patent
LanguageEnglish
French
Published 09.02.2006
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin-3 (NK-3) receptors, such as schizophrenia. La présente invention concerne des composés représentés par la formule (I) et leurs sels pharmaceutiquement acceptables, les compositions pharmaceutiques qui les contiennent et leur utilisation dans le traitement des maladies induites par les récepteurs de la neurokinine-2 et/ou neurokinine-3 (NK-3), telle que la schizophrénie.
Bibliography:Application Number: WO2005GB50121